SpringerLink
Log in

Rapidly Growing Mycobacterial Infections in Transplant: Evolving Epidemiology and Treatment Options

  • Living reference work entry
  • Latest version View entry history
  • First Online:
Emerging Transplant Infections

  • 62 Accesses

Abstract

Rapidly growing mycobacteria (RGM) are environmental microorganisms that thrive in water-associated biofilms and grow more quickly in the laboratory than slow-growing nontuberculous mycobacteria. Prevalence of RGM infection appears to be increasing, and patients with structural lung disease and immunocompromised hosts, especially patients with cystic fibrosis or lung transplant recipients, are at increased risk. Transplant recipients can acquire RGM from the community or from healthcare facilities, and several recent RGM outbreaks have occurred at hospitals with transplant programs. Diagnosis of RGM infection in transplant patients is challenging and often delayed due to indolent, atypical presentations and decreased sensitivity of culture. Treatment requires prolonged combination antimicrobial therapy, and many invasive RGM infections also require surgical debridement. Even with aggressive therapy, however, transplant patients with RGM infections commonly fail to achieve cure, and antibiotic-related toxicities are common. Development of more effective and better-tolerated therapies for both transplant recipients and candidates for transplantation with RGM infection represents an emerging need. In addition, close adherence to infection prevention measures is critical; strategies for prevention should be based upon local RGM and transplant epidemiology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Brown-Elliott BA, Philley JV. Rapidly growing mycobacteria. Microbiol Spectr. 2017;5(1):1–19.

    Google Scholar 

  2. Wentworth AB, Drage LA, Wengenack NL, Wilson JW, Lohse CM. Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study. Mayo Clin Proc. 2013;88(1):38–45.

    Google Scholar 

  3. Alcaide F, Pena MJ, Perez-Risco D, Camprubi D, Gonzalez-Luquero L, Grijota-Camino MD, et al. Increasing isolation of rapidly growing mycobacteria in a low-incidence setting of environmental mycobacteria, 1994–2015. Eur J Clin Microbiol Infect Dis. 2017;36(8):1425–32.

    Article  CAS  PubMed  Google Scholar 

  4. Velayati AA, Rahideh S, Nezhad ZD, Farnia P, Mirsaeidi M. Nontuberculous mycobacteria in Middle East: current situation and future challenges. Int J Mycobacteriol. 2015;4(1):7–17.

    Article  PubMed  Google Scholar 

  5. George IA, Santos CA, Olsen MA, Bailey TC. Epidemiology and outcomes of nontuberculous mycobacterial infections in solid organ transplant recipients at a Midwestern center. Transplantation. 2016;100(5):1073–8.

    Article  PubMed  Google Scholar 

  6. Longworth SA, Vinnard C, Lee I, Sims KD, Barton TD, Blumberg EA. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study. Transpl Infect Dis. 2014;16(1):76–83.

    Article  CAS  PubMed  Google Scholar 

  7. Baker AW, Lewis SS, Alexander BD, Chen LF, Wallace RJ Jr, Brown-Elliott BA, et al. Two-phase hospital-associated outbreak of Mycobacterium abscessus: investigation and mitigation. Clin Infect Dis. 2017;64(7):902–11.

    PubMed  PubMed Central  Google Scholar 

  8. Iroh Tam PY, Kline S, Wagner JE, Guspiel A, Streifel A, Ward G, et al. Rapidly growing mycobacteria among pediatric hematopoietic cell transplant patients traced to the hospital water supply. Pediatr Infect Dis J. 2014;33(10):1043–6.

    Article  PubMed  Google Scholar 

  9. Guspiel A, Menk J, Streifel A, Messinger K, Wagner J, Ferrieri P, et al. Management of risks from water and ice from ice machines for the very immunocompromised host: a process improvement project prompted by an outbreak of rapidly growing mycobacteria on a pediatric hematopoietic stem cell transplant (Hsct) unit. Infect Control Hosp Epidemiol. 2017;38(7):792–800.

    Article  PubMed  Google Scholar 

  10. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.

    Article  CAS  PubMed  Google Scholar 

  11. Ward JGMaAC. Bergey’s manual of systematics of archaea and bacteria. In: Whitman WB, editor. Mycobacteriaceae. John Wiley and Sons, Hoboken, NJ; 2015.

    Google Scholar 

  12. Knoll BM, Kappagoda S, Gill RR, Goldberg HJ, Boyle K, Baden LR, et al. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study. Transpl Infect Dis. 2012;14(5):452–60.

    Article  CAS  PubMed  Google Scholar 

  13. Baker AW, Maziarz EK, Saullo JH, Arif S, Anderson DJ, Alexander BD, et al. Mycobacterium abscessus infection in solid organ transplant recipients. Open Forum Infect Dis. 2016;3(suppl_1):2311.

    Article  Google Scholar 

  14. Maziarz EK, Baker AW, Patel CB, Patel P, Milano CA, Schroder JN, et al. Invasive Mycobacterium abscessus infection in heart transplant recipients. J Heart Lung Transplant. 2017;36(4, Supplement):S25.

    Article  Google Scholar 

  15. Garrison AP, Morris MI, Doblecki Lewis S, Smith L, Cleary TJ, Procop GW, et al. Mycobacterium abscessus infection in solid organ transplant recipients: report of three cases and review of the literature. Transpl Infect Dis. 2009;11(6):541–8.

    Article  CAS  PubMed  Google Scholar 

  16. Wallace RJ Jr, Zhang Y, Brown BA, Fraser V, Mazurek GH, Maloney S. DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol. 1993;31(10):2697–701.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Morales P, Gil A, Santos M. Mycobacterium abscessus infection in transplant recipients. Transplant Proc. 2010;42(8):3058–60.

    Article  CAS  PubMed  Google Scholar 

  18. Richey LE, Bahadorani J, Mushatt D. Endovascular Mycobacterium abscessus infection in a heart transplant recipient: a case report and review of the literature. Transpl Infect Dis. 2013;15(2):208–13.

    Article  CAS  PubMed  Google Scholar 

  19. Uyan ZS, Ersu R, Oktem S, Cakir E, Koksalan OK, Karadag B, et al. Mycobacterium abscessus infection in a cystic fibrosis patient: a difficult to treat infection. Int J Tuberc Lung Dis. 2010;14(2):250–1.

    CAS  PubMed  Google Scholar 

  20. Lee MR, Sheng WH, Hung CC, Yu CJ, Lee LN, Hsueh PR. Mycobacterium abscessus complex infections in humans. Emerg Infect Dis. 2015;21(9):1638–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Aitken ML, Limaye A, Pottinger P, Whimbey E, Goss CH, Tonelli MR, et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med. 2012;185(2):231–2.

    Article  CAS  PubMed  Google Scholar 

  22. Choi H, Kim SY, Lee H, Jhun BW, Park HY, Jeon K, et al. Clinical characteristics and treatment outcomes of patients with macrolide-resistant mycobacterium massiliense lung disease. Antimicrob Agents Chemother. 2017;61(2):e02189–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Park J, Cho J, Lee CH, Han SK, Yim JJ. Progression and treatment outcomes of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense. Clin Infect Dis. 2017;64(3):301–8.

    Article  CAS  PubMed  Google Scholar 

  24. Tettelin H, Davidson RM, Agrawal S, Aitken ML, Shallom S, Hasan NA, et al. High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks. Emerg Infect Dis. 2014;20(3):364–71.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Huth RG, Douglass E, Mondy K, Vasireddy S, Wallace RJ Jr. Treatment of Mycobacterium abscessus subsp. massiliense tricuspid valve endocarditis. Emerg Infect Dis. 2015;21(3):535–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Miyake N, Chong Y, Nishida R, Takenaka K, Kato K, Miyamoto T, et al. Mycobacterium abscessus and massiliense lung infection during macrolide treatment for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2018;24(1):78–81.

    Article  PubMed  Google Scholar 

  27. Wallace RJ Jr, Dukart G, Brown-Elliott BA, Griffith DE, Scerpella EG, Marshall B. Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections. J Antimicrob Chemother. 2014;69(7):1945–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Somily AM, Al-Anazi AR, Babay HA, Al-Aska AI, Al-Hedaithy MA, Al-Hamoudi WK, et al. Mycobacterium chelonae complex bacteremia from a post-renal transplant patient: case report and literature review. Jpn J Infect Dis. 2010;63(1):61–4.

    Article  PubMed  Google Scholar 

  29. Kim JE, Sung H, Kim MN, Won CH, Chang SE, Lee MW, et al. Synchronous infection with Mycobacterium chelonae and Paecilomyces in a heart transplant patient. Transpl Infect Dis. 2011;13(1):80–3.

    Article  PubMed  Google Scholar 

  30. Chatzikokkinou P, Luzzati R, Sotiropoulos K, Katsambas A, Trevisan G. Disseminated cutaneous infection with Mycobacterium chelonae in a renal transplant recipient. Cutis. 2015;96(5):E6–9.

    PubMed  Google Scholar 

  31. Biggs HM, Chudgar SM, Pfeiffer CD, Rice KR, Zaas AK, Wolfe CR. Disseminated Mycobacterium immunogenum infection presenting with septic shock and skin lesions in a renal transplant recipient. Transpl Infect Dis. 2012;14(4):415–21.

    Article  CAS  PubMed  Google Scholar 

  32. Simmon KE, Brown-Elliott BA, Ridge PG, Durtschi JD, Mann LB, Slechta ES, et al. Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease. Northeastern USA Emerg Infect Dis. 2011;17(9):1692–700.

    Article  CAS  PubMed  Google Scholar 

  33. Shah SK, McAnally KJ, Seoane L, Lombard GA, LaPlace SG, Lick S, et al. Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation. Transpl Infect Dis. 2016;18(4):585–91.

    Article  CAS  PubMed  Google Scholar 

  34. El Helou G, Hachem R, Viola GM, El Zakhem A, Chaftari AM, Jiang Y, et al. Management of rapidly growing mycobacterial bacteremia in cancer patients. Clin Infect Dis. 2013;56(6):843–6.

    Article  PubMed  Google Scholar 

  35. Han XY, De I, Jacobson KL. Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol. 2007;128(4):612–21.

    Article  PubMed  Google Scholar 

  36. Adzic-Vukicevic T, Barac A, Blanka-Protic A, Laban-Lazovic M, Lukovic B, Skodric-Trifunovic V, et al. Clinical features of infection caused by non-tuberculous mycobacteria: 7 years’ experience. Infection. 2018;46(3):357–63.

    Article  PubMed  Google Scholar 

  37. Oh WS, Ko KS, Song JH, Lee MY, Ryu SY, Taek S, et al. Catheter-associated bacteremia by Mycobacterium senegalense in Korea. BMC Infect Dis. 2005;5:107.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Brown-Elliott BA, Wallace RJ Jr, Tichindelean C, Sarria JC, McNulty S, Vasireddy R, et al. Five-year outbreak of community- and hospital-acquired Mycobacterium porcinum infections related to public water supplies. J Clin Microbiol. 2011;49(12):4231–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002;15(4):716–46.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Poh ME, Liam CK, Ng KP, Tan R. Mycobacterium brisbanense species nova isolated from a patient with chronic cavitary lung infection. Chest. 2014;145(4):858–60.

    Article  PubMed  Google Scholar 

  41. Toro A, Adekambi T, Cheynet F, Fournier PE, Drancourt M. Mycobacterium setense infection in humans. Emerg Infect Dis. 2008;14(8):1330–2.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Saffo Z, Ognjan A. Mycobacterium smegmatis infection of a prosthetic total knee arthroplasty. IDCases. 2016;5:80–2.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Ferguson DD, Gershman K, Jensen B, Arduino MJ, Yakrus MA, Cooksey RC, et al. Mycobacterium goodii infections associated with surgical implants at Colorado hospital. Emerg Infect Dis. 2004;10(10):1868–71.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Yoo DK, Hosseini-Moghaddam SM. Pacemaker pocket infection due to Mycobacterium goodii, a rapidly growing mycobacteria. BMJ Case Rep. 2017;2017:bcr2016218323.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Tagashira Y, Kozai Y, Yamasa H, Sakurada M, Kashiyama T, Honda H. A cluster of central line-associated bloodstream infections due to rapidly growing nontuberculous mycobacteria in patients with hematologic disorders at a Japanese tertiary care center: an outbreak investigation and review of the literature. Infect Control Hosp Epidemiol. 2015;36(1):76–80.

    Article  PubMed  Google Scholar 

  46. Maybrook RJ, Campsen J, Wachs ME, Levi ME. A case of Mycobacterium mucogenicum infection in a liver transplant recipient and a review of the literature. Transpl Infect Dis. 2013;15(6):E260–3.

    Article  CAS  PubMed  Google Scholar 

  47. Shachor-Meyouhas Y, Geffen Y, Arad-Cohen N, Zaidman I, Ben-Barak A, Davidson S, et al. Mycobacterium phocaicum bacteremia: an emerging infection in pediatric hematology-oncology patients. Pediatr Infect Dis J. 2014;33(12):1299–301.

    Article  PubMed  Google Scholar 

  48. McMullen AR, Mattar C, Kirmani N, Burnham CA. Brown-pigmented Mycobacterium mageritense as a cause of prosthetic valve endocarditis and bloodstream infection. J Clin Microbiol. 2015;53(8):2777–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Ali S, Khan FA, Fisher M. Catheter-related bloodstream infection caused by Mycobacterium mageritense. J Clin Microbiol. 2007;45(1):273.

    Article  PubMed  Google Scholar 

  50. Appelgren P, Farnebo F, Dotevall L, Studahl M, Jonsson B, Petrini B. Late-onset posttraumatic skin and soft-tissue infections caused by rapid-growing mycobacteria in tsunami survivors. Clin Infect Dis. 2008;47(2):e11–6.

    Article  PubMed  Google Scholar 

  51. Ariza-Heredia EJ, Dababneh AS, Wilhelm MP, Wengenack NL, Razonable RR, Wilson JW. Mycobacterium wolinskyi: a case series and review of the literature. Diagn Microbiol Infect Dis. 2011;71(4):421–7.

    Article  PubMed  Google Scholar 

  52. Vutescu ES, Koenig KM. Mycobacterium cosmeticum infection after total knee arthroplasty: a case report. JBJS Case Connector. 2017;7(1):e3.

    Article  PubMed  Google Scholar 

  53. Taieb A, Ikeguchi R, Yu VL, Rihs JD, Sharma M, Wolfe J, et al. Mycobacterium monacense: a mycobacterial pathogen that causes infection of the hand. J Hand Surg. 2008;33(1):94–6.

    Article  Google Scholar 

  54. Brown-Elliott BA, Wallace RJ Jr, Petti CA, Mann LB, McGlasson M, Chihara S, et al. Mycobacterium neoaurum and Mycobacterium bacteremicum sp. nov. as causes of mycobacteremia. J Clin Microbiol. 2010;48(12):4377–85.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Song Y, Wu J, Yan H, Chen J. Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant. 2012;27(4):1639–44.

    Article  PubMed  Google Scholar 

  56. Nunez Breton JD, Hernandez G, Simkins J, Chaparro SV. Mycobacterium abscessus left ventricle assist device driveline infections: an emerging pathogen? Transpl Infect Dis. 2018;20(5):e12957.

    Article  PubMed  Google Scholar 

  57. Phadke VK, Hirsh DS, Goswami ND. Patient report and review of rapidly growing mycobacterial infection after cardiac device implantation. Emerg Infect Dis. 2016;22(3):389–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med. 2015;36(1):13–34.

    Article  PubMed  Google Scholar 

  59. Spaulding AB, Lai YL, Zelazny AM, Olivier KN, Kadri SS, Prevots DR, et al. Geographic distribution of nontuberculous mycobacterial species identified among clinical isolates in the United States, 2009–2013. Ann Am Thorac Soc. 2017;14(11):1655–61.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Doucette K, Fishman JA. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis. 2004;38(10):1428–39.

    Article  PubMed  Google Scholar 

  61. Chalermskulrat W, Sood N, Neuringer IP, Hecker TM, Chang L, Rivera MP, et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax. 2006;61(6):507–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Novick RJ, Moreno-Cabral CE, Stinson EB, Oyer PE, Starnes VA, Hunt SA, et al. Nontuberculous mycobacterial infections in heart transplant recipients: a seventeen-year experience. J Heart Transplant. 1990;9(4):357–63.

    CAS  PubMed  Google Scholar 

  63. Thomson R, Tolson C, Sidjabat H, Huygens F, Hargreaves M. Mycobacterium abscessus isolated from municipal water – a potential source of human infection. BMC Infect Dis. 2013;13:241.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Kennedy BS, Bedard B, Younge M, Tuttle D, Ammerman E, Ricci J, et al. Outbreak of Mycobacterium chelonae infection associated with tattoo ink. N Engl J Med. 2012;367(11):1020–4.

    Article  CAS  PubMed  Google Scholar 

  65. Stout JE, Gadkowski LB, Rath S, Alspaugh JA, Miller MB, Cox GM. Pedicure-associated rapidly growing mycobacterial infection: an endemic disease. Clin Infect Dis. 2011;53(8):787–92.

    Article  PubMed  Google Scholar 

  66. Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP, Moreno P, et al. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science. 2016;354(6313):751–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Le Dantec C, Duguet JP, Montiel A, Dumoutier N, Dubrou S, Vincent V. Chlorine disinfection of atypical mycobacteria isolated from a water distribution system. Appl Environ Microbiol. 2002;68(3):1025–32.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  68. Culton DA, Lachiewicz AM, Miller BA, Miller MB, Mackuen C, Groben P, et al. Nontuberculous mycobacterial infection after fractionated CO(2) laser resurfacing. Emerg Infect Dis. 2013;19(3):365–70.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Cho SY, Peck KR, Kim J, Ha YE, Kang CI, Chung DR, et al. Mycobacterium chelonae infections associated with bee venom acupuncture. Clin Infect Dis. 2014;58(5):e110–3.

    Article  PubMed  Google Scholar 

  70. Kanamori H, Weber DJ, Rutala WA. Healthcare outbreaks associated with a water reservoir and infection prevention strategies. Clin Infect Dis. 2016;62(11):1423–35.

    Article  PubMed  Google Scholar 

  71. Shin JH, Lee EJ, Lee HR, Ryu SM, Kim HR, Chang CL, et al. Prevalence of non-tuberculous mycobacteria in a hospital environment. J Hosp Infect. 2007;65(2):143–8.

    Article  CAS  PubMed  Google Scholar 

  72. Schnabel D, Esposito DH, Gaines J, Ridpath A, Barry MA, Feldman KA, et al. Multistate US outbreak of rapidly growing mycobacterial infections associated with medical tourism to the Dominican Republic, 2013–2014(1). Emerg Infect Dis. 2016;22(8):1340–7.

    Article  PubMed  PubMed Central  Google Scholar 

  73. van Ingen J, Kohl TA, Kranzer K, Hasse B, Keller PM, Katarzyna Szafranska A, et al. Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study. Lancet Infect Dis. 2017;17(10):1033–41.

    Article  PubMed  Google Scholar 

  74. Bryant JM, Grogono DM, Greaves D, Foweraker J, Roddick I, Inns T, et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet. 2013;381(9877):1551–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Doyle RM, Rubio M, Dixon G, Hartley J, Klein N, Coll P, et al. Cross-transmission is not the source of new Mycobacterium abscessus infections in a multi-centre cohort of cystic fibrosis patients. Clin Infect Dis. 2019. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciz526/5521616

  76. Tortoli E, Kohl TA, Trovato A, Baldan R, Campana S, Cariani L, et al. Mycobacterium abscessus in patients with cystic fibrosis: low impact of inter-human transmission in Italy. Eur Respir J. 2017;50(1):1602525.

    Article  PubMed  Google Scholar 

  77. Chau CL, Griffith JF, Chan PT, Lui TH, Yu KS, Ngai WK. Rice-body formation in atypical mycobacterial tenosynovitis and bursitis: findings on sonography and MR imaging. AJR Am J Roentgenol. 2003;180(5):1455–9.

    Article  CAS  PubMed  Google Scholar 

  78. Franco-Paredes C, Marcos LA, Henao-Martinez AF, Rodriguez-Morales AJ, Villamil-Gomez WE, Gotuzzo E, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev. 2018;32(1):e00069–18.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Vetter E, Torgerson C, Feuker A, Hughes J, Harmsen S, Schleck C, et al. Comparison of the BACTEC MYCO/F Lytic bottle to the isolator tube, BACTEC Plus Aerobic F/bottle, and BACTEC Anaerobic Lytic/10 bottle and comparison of the BACTEC Plus Aerobic F/bottle to the Isolator tube for recovery of bacteria, mycobacteria, and fungi from blood. J Clin Microbiol. 2001;39(12):4380–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Toney NC, Toney SR, Butler WR. Utility of high-performance liquid chromatography analysis of mycolic acids and partial 16S rRNA gene sequencing for routine identification of Mycobacterium spp. in a national reference laboratory. Diagn Microbiol Infect Dis. 2010;67(2):143–52.

    Article  CAS  PubMed  Google Scholar 

  81. Luo L, Cao W, Chen W, Zhang R, **g L, Chen H, et al. Evaluation of the VITEK MS knowledge base version 3.0 for the identification of clinically relevant Mycobacterium species. Emerg Microbes Infect. 2018;7(1):114.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Body BA, Beard MA, Slechta ES, Hanson KE, Barker AP, Babady NE, et al. Evaluation of the Vitek MS v3.0 matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Mycobacterium and Nocardia species. J Clin Microbiol. 2018;56(6):e00237–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Miller E, Cantrell C, Beard M, Derylak A, Babady NE, McMillen T, et al. Performance of Vitek MS v3.0 for identification of mycobacterium species from patient samples by use of automated liquid medium systems. J Clin Microbiol. 2018;56(8):e00219–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Jeon K, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med. 2009;180(9):896–902.

    Article  CAS  PubMed  Google Scholar 

  85. Brown-Elliott BA, Nash KA, Wallace RJ Jr. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev. 2012;25(3):545–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Brown-Elliott BA, Killingley J, Vasireddy S, Bridge L, Wallace RJ Jr. In vitro comparison of ertapenem, meropenem, and imipenem against isolates of rapidly growing mycobacteria and nocardia by use of broth microdilution and Etest. J Clin Microbiol. 2016;54(6):1586–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Brown-Elliott BA, Wallace RJ Jr. In vitro susceptibility testing of tedizolid against nontuberculous mycobacteria. J Clin Microbiol. 2017;55(6):1747–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, et al. In vitro antimicrobial susceptibility of nontuberculous mycobacteria in Iran. Microb Drug Resist. 2016;22(2):172–8.

    Article  CAS  PubMed  Google Scholar 

  89. Choi H, Jhun BW, Kim SY, Kim DH, Lee H, Jeon K, et al. Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease. Diagn Microbiol Infect Dis. 2018;90(4):293–5.

    Article  PubMed  Google Scholar 

  90. Koh WJ, Jeong BH, Kim SY, Jeon K, Park KU, Jhun BW, et al. Mycobacterial characteristics and treatment outcomes in mycobacterium abscessus lung disease. Clin Infect Dis. 2017;64(3):309–16.

    Article  CAS  PubMed  Google Scholar 

  91. Choi H, Kim SY, Kim DH, Huh HJ, Ki CS, Lee NY, et al. Clinical characteristics and treatment outcomes of patients with acquired macrolide-resistant mycobacterium abscessus lung disease. Antimicrob Agents Chemother. 2017;61(10):e01146–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Choi GE, Shin SJ, Won CJ, Min KN, Oh T, Hahn MY, et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med. 2012;186(9):917–25.

    Article  CAS  PubMed  Google Scholar 

  93. Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009;53(4):1367–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Brown-Elliott BA, Vasireddy S, Vasireddy R, Iakhiaeva E, Howard ST, Nash K, et al. Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs. J Clin Microbiol. 2015;53(4):1211–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Brown-Elliott BA, Hanson K, Vasireddy S, Iakhiaeva E, Nash KA, Vasireddy R, et al. Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility. J Clin Microbiol. 2015;53(3):875–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  96. Rapp RP. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions. Ann Pharmacother. 1998;32(7–8):785–93.

    Article  CAS  PubMed  Google Scholar 

  97. Amacher DE, Schomaker SJ, Retsema JA. Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. Antimicrob Agents Chemother. 1991;35(6):1186–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Wallace RJ Jr, Meier A, Brown BA, Zhang Y, Sander P, Onyi GO, et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother. 1996;40(7):1676–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Ferro BE, Srivastava S, Deshpande D, Pasipanodya JG, van Soolingen D, Mouton JW, et al. Tigecycline is highly efficacious against mycobacterium abscessus pulmonary disease. Antimicrob Agents Chemother. 2016;60(5):2895–900.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Philley JV, Wallace RJ Jr, Benwill JL, Taskar V, Brown-Elliott BA, Thakkar F, et al. Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease. Chest. 2015;148(2):499–506.

    Article  PubMed  PubMed Central  Google Scholar 

  101. McGuffin SA, Pottinger PS, Harnisch JP. Clofazimine in nontuberculous mycobacterial infections: a growing niche. Open Forum Infect Dis. 2017;4(3):ofx147.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  102. Bax HI, de Vogel CP, Mouton JW, de Steenwinkel JEM. Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus. J Antimicrob Chemother. 2019;74(10):2930–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Kaushik A, Ammerman NC, Martins O, Parrish NM, Nuermberger EL. In vitro activity of new tetracycline analogs omadacycline and eravacycline against drug-resistant clinical isolates of Mycobacterium abscessus. Antimicrob Agents Chemother. 2019;63(6):e00470–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Yuste JR, Bertó J, Del Pozo JL, Leiva J. Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity. J Antimicrob Chemother. 2017;72(2):625–8.

    Article  CAS  PubMed  Google Scholar 

  105. Brown-Elliott BA, Wallace RJ Jr. In vitro susceptibility testing of bedaquiline against Mycobacterium abscessus complex. Antimicrob Agents Chemother. 2019;63(2):e01919–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. van Ingen J, Totten SE, Helstrom NK, Heifets LB, Boeree MJ, Daley CL. In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease. Antimicrob Agents Chemother. 2012;56(12):6324–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  107. Martiniano SL, Wagner BD, Levin A, Nick JA, Sagel SD, Daley CL. Safety and effectiveness of clofazimine for primary and refractory nontuberculous mycobacterial infection. Chest. 2017;152(4):800–9.

    Article  PubMed  Google Scholar 

  108. Cariello PF, Kwak EJ, Abdel-Massih RC, Silveira FP. Safety and tolerability of clofazimine as salvage therapy for atypical mycobacterial infection in solid organ transplant recipients. Transpl Infect Dis. 2015;17(1):111–8.

    Article  CAS  PubMed  Google Scholar 

  109. Osmani M, Sotello D, Alvarez S, Odell JA, Thomas M. Mycobacterium abscessus infections in lung transplant recipients: 15-year experience from a single institution. Transpl Infect Dis. 2018;20(2):e12835.

    Article  PubMed  CAS  Google Scholar 

  110. Chandrashekaran S, Escalante P, Kennedy CC. Mycobacterium abscessus disease in lung transplant recipients: diagnosis and management. J Clin Tuberc Other Mycobact Dis. 2017;9:10–8.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Dedrick RM, Guerrero-Bustamante CA, Garlena RA, Russell DA, Ford K, Harris K, et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 2019;25(5):730–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Longworth SA, Blumberg EA, Barton TD, Vinnard C. Non-tuberculous mycobacterial infections after solid organ transplantation: a survival analysis. Clin Microbiol Infect. 2015;21(1):43–7.

    Article  CAS  PubMed  Google Scholar 

  113. Olivier KN, Shaw PA, Glaser TS, Bhattacharyya D, Fleshner M, Brewer CC, et al. Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. Ann Am Thorac Soc. 2014;11(1):30–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Safdar A. Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis. Eur J Clin Microbiol Infect Dis. 2012;31(8):1883–7.

    Article  CAS  PubMed  Google Scholar 

  115. Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, et al. Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT): a prospective, open-label, randomized study. Am J Respir Crit Care Med. 2018;198(12):1559–69.

    Article  CAS  PubMed  Google Scholar 

  116. Olivier KN, Griffith DE, Eagle G, McGinnis JP 2nd, Micioni L, Liu K, et al. Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease. Am J Respir Crit Care Med. 2017;195(6):814–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Diel R, Ringshausen F, Richter E, Welker L, Schmitz J, Nienhaus A. Microbiological and clinical outcomes of treating non-Mycobacterium avium complex nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis. Chest. 2017;152(1):120–42.

    Article  PubMed  Google Scholar 

  118. Kotecha S, Smibert OC, Doi A, Gooi J, Morrissey O, Paraskeva M, et al. A successful aggressive surgical and medical approach to pulmonary artery obstruction due to Mycobacterium abscessus infection post lung transplantation. Transpl Infect Dis. 2018;20(2):e12838.

    Article  PubMed  Google Scholar 

  119. Unai S, Miessau J, Karbowski P, Bajwa G, Hirose H. Sternal wound infection caused by Mycobacterium chelonae. J Card Surg. 2013;28(6):687–92.

    Article  PubMed  Google Scholar 

  120. El Helou G, Viola GM, Hachem R, Han XY, Raad II. Rapidly growing mycobacterial bloodstream infections. Lancet Infect Dis. 2013;13(2):166–74.

    Article  PubMed  Google Scholar 

  121. Keating MR, Daly JS. Nontuberculous mycobacterial infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):77–82.

    Article  CAS  PubMed  Google Scholar 

  122. Novosad SA, Beekmann SE, Polgreen PM, Mackey K, Winthrop KL, Team MaS. Treatment of Mycobacterium abscessus infection. Emerg Infect Dis. 2016;22(3):511–514.

    Google Scholar 

  123. De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis. 2006;42(12):1756–63.

    Article  PubMed  Google Scholar 

  124. Vasconcelos KA, Frota S, Ruffino-Netto A, Kritski AL. The importance of audiometric monitoring in patients with multidrug-resistant tuberculosis. Rev Soc Bras Med Trop. 2017;50(5):646–51.

    Article  PubMed  Google Scholar 

  125. Kranzer K, Elamin WF, Cox H, Seddon JA, Ford N, Drobniewski F. A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB. Thorax. 2015;70(11):1070–7.

    Article  PubMed  Google Scholar 

  126. Agyeman AA, Ofori-Asenso R. Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2016;15(1):41.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  127. Lemoine M, Laurent C, Hanoy M, Leporrier J, Francois A, Guerrot D, et al. Immune reconstitution inflammatory syndrome secondary to Mycobacterium kansasii infection in a kidney transplant recipient. Am J Transplant. 2015;15(12):3255–8.

    Article  CAS  PubMed  Google Scholar 

  128. Avery RK, Michaels MG, Practice ASTIDCo. Strategies for safe living following solid organ transplantation. Am J Transplant. 2009;9(Suppl 4):S252–7.

    Article  PubMed  Google Scholar 

  129. Crist MB, Perz JF. Modern healthcare versus nontuberculous mycobacteria: who will have the upper hand? Clin Infect Dis. 2017;64(7):912–3.

    PubMed  Google Scholar 

  130. Baker AW, Smith B, Sexton DJ, Huslage K, Stout JE, Anderson DJ, et al. 927. Tap water avoidance decreases rates of nontuberculous mycobacteria in intensive care units. Open Forum Infect Dis. 2018;5(Suppl 1):S29–30.

    Article  PubMed Central  Google Scholar 

  131. Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S, et al. A consensus document for the selection of lung transplant candidates: 2014 – an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015;34(1):1–15.

    Article  PubMed  Google Scholar 

  132. Floto RA, Olivier KN, Saiman L, Daley CL, Herrmann JL, Nick JA, et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71(Suppl 1):i1–22.

    Article  PubMed  Google Scholar 

  133. Tissot A, Thomas MF, Corris PA, Brodlie M. NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice. BMC Pulm Med. 2018;18(1):86.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Rao M, Silveira FP. Non-tuberculous Mycobacterial infections in thoracic transplant candidates and recipients. Curr Infect Dis Rep. 2018;20(6):14.

    Article  PubMed  Google Scholar 

  135. Lobo LJ, Chang LC, Esther CR Jr, Gilligan PH, Tulu Z, Noone PG. Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections. Clin Transpl. 2013;27(4):523–9.

    Article  Google Scholar 

  136. Gilljam M, Schersten H, Silverborn M, Jonsson B, Ericsson HA. Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection. J Cyst Fibros. 2010;9(4):272–6.

    Article  PubMed  Google Scholar 

  137. Roux AL, Catherinot E, Soismier N, Heym B, Bellis G, Lemonnier L, et al. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. J Cyst Fibros. 2015;14(1):63–9.

    Article  PubMed  Google Scholar 

  138. Wolfe CR, Baker AW, Patel CB, Patel PA, Milano CA, Schroder JN, et al. Mycobacterium abscessus infection in patients with ventricular assist devices. J Heart Lung Transplant. 2017;36(4 Supplement):S257–S8.

    Article  Google Scholar 

  139. Shachor-Meyouhas Y, Sprecher H, Eluk O, Ben-Barak A, Kassis I. An outbreak of Mycobacterium mucogenicum bacteremia in pediatric hematology-oncology patients. Pediatr Infect Dis J. 2011;30(1):30–2.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA

    Nicholas A. Turner & Arthur W. Baker

  2. Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC, USA

    Nicholas A. Turner & Arthur W. Baker

Authors
  1. Nicholas A. Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arthur W. Baker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arthur W. Baker .

Editor information

Editors and Affiliations

  1. Miller School of Medicine, University of Miami, Miami, FL, USA

    Michele I. Morris

  2. Massachusetts General Hospital, Harvard University, Boston, MA, USA

    Camille Nelson Kotton

  3. Duke University, Durham, NC, USA

    Cameron Wolfe

Section Editor information

  1. Duke University, Durham, NC, USA

    Cameron R. Wolfe

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Turner, N.A., Baker, A.W. (2021). Rapidly Growing Mycobacterial Infections in Transplant: Evolving Epidemiology and Treatment Options. In: Morris, M.I., Kotton, C.N., Wolfe, C. (eds) Emerging Transplant Infections. Springer, Cham. https://doi.org/10.1007/978-3-030-01751-4_16-3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-01751-4_16-3

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-01751-4

  • Online ISBN: 978-3-030-01751-4

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Rapidly Growing Mycobacterial Infections in Transplant: Evolving Epidemiology and Treatment Options
    Published:
    21 January 2021

    DOI: https://doi.org/10.1007/978-3-030-01751-4_16-3

  2. Rapidly Growing Mycobacterial Infections in Transplant: Evolving Epidemiology and Treatment Options
    Published:
    04 December 2020

    DOI: https://doi.org/10.1007/978-3-030-01751-4_16-2

  3. Original

    Rapidly Growing Mycobacterial Infections in Transplant: Evolving Epidemiology and Treatment Options
    Published:
    23 January 2020

    DOI: https://doi.org/10.1007/978-3-030-01751-4_16-1

Search

Navigation